StemCore is becoming a local provider for the Allen Institute’s iPS reporter cell line collection and their derivatives
StemCore is a state-of-the-art, not-for-profit comprehensive pluripotent stem cell and human functional genomics core facility that offers a wide range of services to biologists, from the stem cell and other fields, interested in human genome editing and functional genomics. These services include provision of NIH-listed human Embryonic Stem Cell lines (hESCs), off-the-shelf and custom-generated (using latest reprogramming methods) induced pluripotent stem cells (iPSCs), and hESCs and iPSCs genetically engineered using CRISPR/Cas9 and other approaches, as well as a wide range of transgenic human pluripotent stem cell tools, genotyping, mycoplasma detection, teratoma, karyotyping, and other assays.
At StemCore, we believe in the potential of the regenerative medicine, and in giving academic research the best support it can get. Because together, we can work towards the better understanding and eradication of degenerative diseases. Our activity has long been generously supported by Bioplatforms Australia through funding from the Australian Government’s National Collaborative Research Infrastructure Strategy (NCRIS) scheme.
We are currently working on bringing the latest technologies and tools for the rapidly-evolving field of human cell functional genomics to the researchers across Australia and around the globe.